These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6682161)

  • 1. Treatment of advanced malignant hemangiopericytoma with combination adriamycin and DTIC: a report of four cases.
    Beadle GF; Hillcoat BL
    J Surg Oncol; 1983 Mar; 22(3):167-70. PubMed ID: 6682161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination chemotherapy using adriamycin, DTIC, cyclophosphamide, and actinomycin D for advanced soft tissue sarcomas: a randomized comparative trial. A phase III, Southwest Oncology Group Study (7613).
    Baker LH; Frank J; Fine G; Balcerzak SP; Stephens RL; Stuckey WJ; Rivkin S; Saiki J; Ward JH
    J Clin Oncol; 1987 Jun; 5(6):851-61. PubMed ID: 3295129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy of malignant hemangiopericytoma.
    Wong PP; Yagoda A
    Cancer; 1978 Apr; 41(4):1256-60. PubMed ID: 346193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metastatic sarcomas: chemotherapy with adriamycin, cyclophosphamide, and methotrexate alternating with actinomycin D, DTIC, and vincristine.
    Presant CA; Lowenbraun S; Bartolucci AA; Smalley RV
    Cancer; 1981 Feb; 47(3):457-65. PubMed ID: 7225999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [5-Fluorouracil, adriamycin, and mitomycin C (FAM) combination chemotherapy in adenocarcinoma of the parotid gland].
    Inoue K; Horikoshi N; Mukaiyama T; Ogawa M; Kuraishi Y
    Gan No Rinsho; 1989 Mar; 35(4):481-5. PubMed ID: 2654442
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequential salvage chemotherapy for recurrent intracranial hemangiopericytoma.
    Chamberlain MC; Glantz MJ
    Neurosurgery; 2008 Oct; 63(4):720-6; author reply 726-7. PubMed ID: 18981882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized comparison of three adriamycin regimens for metastatic soft tissue sarcomas.
    Borden EC; Amato DA; Rosenbaum C; Enterline HT; Shiraki MJ; Creech RH; Lerner HJ; Carbone PP
    J Clin Oncol; 1987 Jun; 5(6):840-50. PubMed ID: 3585441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DTIC therapy in patients with malignant intra-abdominal neuroendocrine tumors.
    Altimari AF; Badrinath K; Reisel HJ; Prinz RA
    Surgery; 1987 Dec; 102(6):1009-17. PubMed ID: 2825370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy of disseminated malignant melanoma with imidazol carboxamide (DTIC) and cyclophosphamide. Preliminary results.
    Rudolf Z; Plesnicar S
    Anticancer Res; 1982; 2(1-2):37-9. PubMed ID: 7051959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant adriamycin and cis-diamminedichloroplatinum (cis-platinum) in primary osteosarcoma.
    Ettinger LJ; Douglass HO; Higby DJ; Mindell ER; Nime F; Ghoorah J; Freeman AI
    Cancer; 1981 Jan; 47(2):248-54. PubMed ID: 6936069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy for extracranial metastases of a primary malignant cerebral neoplasm.
    Oster MW
    Cancer Treat Rep; 1979 Aug; 63(8):1417-8. PubMed ID: 476715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of recurrent ovarian carcinoma with cis-dichlorodiammine platinum II and adriamycin.
    Wallach RC; Cohen C; Bruckner H; Kabakow B; Deppe G; Ratner L
    Obstet Gynecol; 1980 Mar; 55(3):371-2. PubMed ID: 7189048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignant fibrous histiocytoma developing in irradiated sacral chordoma.
    Halpern J; Kopolovic J; Catane R
    Cancer; 1984 Jun; 53(12):2661-2. PubMed ID: 6326989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclophosphamide, vincristine, adriamycin, and DTIC (CYVADIC) combination chemotherapy for the treatment of advanced sarcomas.
    Yap BS; Baker LH; Sinkovics JG; Rivkin SE; Bottomley R; Thigpen T; Burgess MA; Benjamin RS; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):93-8. PubMed ID: 7379060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized study of adriamycin with and without dimethyl triazenoimidazole carboxamide in advanced uterine sarcomas.
    Omura GA; Major FJ; Blessing JA; Sedlacek TV; Thigpen JT; Creasman WT; Zaino RJ
    Cancer; 1983 Aug; 52(4):626-32. PubMed ID: 6344983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of metastatic sarcomas with cyclophosphamide, adriamycin, and DTIC (CAD).
    Blum RH; Corson JM; Wilson RE; Greenberger JS; Canellos GP; Frei E
    Cancer; 1980 Oct; 46(8):1722-6. PubMed ID: 7427876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of advanced ovarian cancer with cis-dichlorodiammine platinum (CDDP) as single agent or cddp in combination with adriamycin (ADM)].
    Nishimura H; Yamada T; Hagio Y; Inoue T; Tsunawaki A; Yakushiji M; Kato T
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 1):938-43. PubMed ID: 6683483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
    Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
    Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide and doxorubicin combination chemotherapy for recurrent nasopharyngeal carcinoma patients.
    Dede DS; Aksoy S; Cengiz M; Gullu I; Altundag K
    Asian Pac J Cancer Prev; 2012; 13(5):2225-8. PubMed ID: 22901198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.